Global Long Read Sequencing Market Report 2022: Potential Applications In Clinical Sequencing And Analysis Present Opportunities – ResearchAndMarkets.com

Global Long Read Sequencing Market Report 2022: Potential Applications In Clinical Sequencing And Analysis Present Opportunities – ResearchAndMarkets.com




Global Long Read Sequencing Market Report 2022: Potential Applications In Clinical Sequencing And Analysis Present Opportunities – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Long Read Sequencing Market Size, Share & Trends Analysis Report by Technology (SMRT Sequencing), by Product, by Application, by Workflow, by End Use, Region and Segment Forecasts, 2022-2030” report has been added to ResearchAndMarkets.com’s offering.

The global long read sequencing market size is expected to reach USD 4.53 billion by 2030, registering a CAGR of 14.74%, according to this report. Since the sequencing method has shown to be of utmost importance in modifying pharmaceuticals, there is also a cumulative market value for the expanding knowledge of long read sequencing. An increase in the adoption of these technologies for the analysis of structural variants is expected to drive the market throughout the forecast period.

Currently, a lot of research is being conducted which is forecast to give manufacturers a slight advantage as they develop new and advanced elongated read sequencing, as well as to open up a lot of other prospects in the long read sequencing market. Furthermore, owing to the ongoing COVID-19 pandemic, key players are working with public health laboratories and researchers around the world to support the current COVID-19 pandemic by rapid sequencing of the novel coronavirus SARS-CoV-2.

Companies are also involved in the development of workflows to characterize a wide range of pathogens in a sample. Recently, Oxford Nanopore Technologies developed LamPORE-a scalable, low-cost, rapid assay for the detection of SARS-CoV-2. A rise in the prevalence of genetic disorders combined with an increase in top manufacturers’ R&D expenditures in long-read sequencing technology is projected to greatly advance the industry. The long read technique is mostly used to study genetic disorders for which disease loci are either well-known or strongly suspected.

In addition, the limitations of clinical disease research based on next-generation sequencing could be partially overcome by these technologies. Since longer reads from a single DNA molecule are used, long-read sequencing methods have a distinct advantage over other technology. Another driver of market expansion is the rising acceptance of contemporary methods for medical diagnosis. The portability and real-time speed of LRS technology are further factors contributing to its rising demand.

It is additionally utilized to create a precise reference map of the chromosome centromere. In addition, numerous biotech firms are creating cutting-edge technologies that combine a fresh approach to library preparation with tools for genomic analysis. Accordingly, a number of researches show that LRS technology is quite useful for identifying novel harmful mutations in human disorders with unidentified genetic origins. This offers a wealth of potential for researchers to use whole-genome sequencing (WGS) technology to develop medical genetics.

Market Dynamics

Market Drivers

  • Advantages Of Long Read Sequencing
  • Potential Applications In Clinical Sequencing And Analysis
  • Advancements In Data Analysis

Market Restraints

  • High Cost
  • Technological Challenges

Long Read Sequencing Market Report Highlights

  • By technology, Single Molecule Real Time Sequencing (SMRT) dominated the market in 2021. This technique is gaining traction among professionals for various applications since the first commercial launch
  • Based on products, the consumables segment accounted for the largest share in 2021. The increasing demand for reagents & kits has majorly driven the segment growth
  • By application, the cancer segment captured the highest share in 2021. The increasing adoption of LRS in the field of cancer biology is anticipated to be the major factor for the segment growth
  • By workflow, sequencing is the dominating segment in 2021. The increasing research in the genomics arena has resulted in growing demand for sequencing services in the global market
  • Based on the end-users, academic research accounted for a significant share in 2021. The presence of a large number of biotechnology institutes that explore genomics methodologies is expected to propel the segment revenue generation
  • North America dominated the global market in 2021 owing to the presence of well-established proteomics, genomics, oncology & diagnostic screening fields in the region
  • Continuous efforts by key players to improve their product offerings is also contributing to the North America’s regional market growth
  • Asia Pacific is anticipated to witness the fastest growth throughout the forecast period. This can be attributed to the growing penetration of key players in Asian countries as well as increasing investments in this field by key players

Key Topics Covered:

Chapter 1 Methodology And Scope

Chapter 2 Executive Summary

Chapter 3 Market Variables, Trends, & Scope

Chapter 4 Long Read Sequencing Market: Technology Business Analysis

Chapter 5 Long Read Sequencing Market: Product Business Analysis

Chapter 6 Long Read Sequencing Market: Application Business Analysis

Chapter 7 Long Read Sequencing Market: Workflow Business Analysis

Chapter 8 Long Read Sequencing Market: End-Use Business Analysis

Chapter 9 Long Read Sequencing Market: Regional Business Analysis

Chapter 10 Company Profiles

Companies Mentioned

  • Pacific Biosciences of California, Inc.
  • Oxford Nanopore Technologies Limited
  • Quantapore, Inc.
  • Stratos Genomics Inc.
  • Microbesng
  • Institute of Integrative Biology of the Cell (I2Bc)
  • Baseclear B.V.
  • Future Genomics Technologies B.V.
  • Garvan Institute of Medical Research
  • Genome Transcriptome Facility of Bordeaux
  • Nextomics
  • Takara Bio

For more information about this report visit https://www.researchandmarkets.com/r/iicerw.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T. Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900